Soňa Hubáčková

1.9k total citations
27 papers, 1.1k citations indexed

About

Soňa Hubáčková is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Soňa Hubáčková has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Physiology and 10 papers in Immunology. Recurrent topics in Soňa Hubáčková's work include Telomeres, Telomerase, and Senescence (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and interferon and immune responses (5 papers). Soňa Hubáčková is often cited by papers focused on Telomeres, Telomerase, and Senescence (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and interferon and immune responses (5 papers). Soňa Hubáčková collaborates with scholars based in Czechia, Denmark and Sweden. Soňa Hubáčková's co-authors include Zdeněk Hodný, Jiří Bártek, Kateřina Krejčíková, Martin Košař, Jiřina Bártková, Jiřı́ Neužil, Jakub Rohlena, Milan Reiniš, Štěpána Boukalová and Zuzana Ezrova and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Free Radical Biology and Medicine.

In The Last Decade

Soňa Hubáčková

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soňa Hubáčková Czechia 15 646 424 246 208 158 27 1.1k
Kwang Seok Kim South Korea 16 497 0.8× 260 0.6× 230 0.9× 162 0.8× 143 0.9× 41 990
Patrycja M. Dubielecka United States 20 652 1.0× 368 0.9× 86 0.3× 93 0.4× 142 0.9× 68 1.1k
Claudia Fiorini Italy 19 587 0.9× 182 0.4× 254 1.0× 199 1.0× 194 1.2× 26 1.1k
David J. Elzi United States 22 524 0.8× 388 0.9× 317 1.3× 115 0.6× 145 0.9× 30 2.1k
Su Myung Jung South Korea 15 451 0.7× 234 0.6× 165 0.7× 148 0.7× 162 1.0× 27 870
Yves Rival France 12 521 0.8× 120 0.3× 249 1.0× 124 0.6× 80 0.5× 15 1.1k
Tracy L. Deem United States 12 484 0.7× 162 0.4× 436 1.8× 101 0.5× 87 0.6× 13 1.1k
Yee Chan‐Li United States 17 383 0.6× 127 0.3× 407 1.7× 205 1.0× 153 1.0× 34 1.1k
Chunmei Piao China 20 483 0.7× 161 0.4× 407 1.7× 156 0.8× 235 1.5× 41 1.3k
Falah Almohanna Saudi Arabia 18 470 0.7× 172 0.4× 201 0.8× 199 1.0× 457 2.9× 49 1.1k

Countries citing papers authored by Soňa Hubáčková

Since Specialization
Citations

This map shows the geographic impact of Soňa Hubáčková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soňa Hubáčková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soňa Hubáčková more than expected).

Fields of papers citing papers by Soňa Hubáčková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soňa Hubáčková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soňa Hubáčková. The network helps show where Soňa Hubáčková may publish in the future.

Co-authorship network of co-authors of Soňa Hubáčková

This figure shows the co-authorship network connecting the top 25 collaborators of Soňa Hubáčková. A scholar is included among the top collaborators of Soňa Hubáčková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soňa Hubáčková. Soňa Hubáčková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cinkajzlová, Anna, et al.. (2025). Coming of age: could obesity-related metabolic complications be treated by targeting senescent cells?. Frontiers in Cell and Developmental Biology. 13. 1622107–1622107. 1 indexed citations
2.
Mráz, Miloš, Petr Svoboda, Helena Kratochvílová, et al.. (2024). Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure. Cardiovascular Diabetology. 23(1). 223–223. 11 indexed citations
3.
Davidová, Eliška, Jan Štursa, Vojtěch Škop, et al.. (2024). Targeting Mitochondrial Integrity as a New Senolytic Strategy. Aging and Disease. 16(6). 3638–3648. 3 indexed citations
4.
Hubáčková, Soňa, et al.. (2022). Phospho-SIM and exon8b of PML protein regulate formation of doxorubicin-induced rDNA-PML compartment. DNA repair. 114. 103319–103319. 2 indexed citations
5.
Boukalová, Štěpána, et al.. (2020). Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(6). 165759–165759. 99 indexed citations
6.
Hubáčková, Soňa, Alena Moudrá, Tomáš Stopka, et al.. (2020). Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes. Molecular Oncology. 14(10). 2403–2419. 6 indexed citations
7.
Hubáčková, Soňa, Eliška Davidová, Štěpána Boukalová, et al.. (2020). Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors. Cell Death and Disease. 11(2). 110–110. 36 indexed citations
8.
Lanikova, Lucie, Ján Gurský, Soňa Hubáčková, et al.. (2019). Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation. Oncogene. 38(28). 5627–5642. 32 indexed citations
9.
Hubáčková, Soňa, Eliška Davidová, Kateřina Rohlenová, et al.. (2018). Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2. Cell Death and Differentiation. 26(2). 276–290. 80 indexed citations
10.
Hubáčková, Soňa, Eliška Davidová, Kateřina Rohlenová, et al.. (2018). Selective elimination of senescent cells by mitochondrial targeting is regulated via ANT2. Free Radical Biology and Medicine. 120. S116–S116. 1 indexed citations
11.
Hubáčková, Soňa, Silvia Magalhaes Novais, Eliška Davidová, Jiřı́ Neužil, & Jakub Rohlena. (2018). Mitochondria-driven elimination of cancer and senescent cells. Biological Chemistry. 400(2). 141–148. 10 indexed citations
12.
Moudrá, Alena, Soňa Hubáčková, Jiří Bártek, et al.. (2016). Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine. OncoImmunology. 5(10). e1183860–e1183860. 19 indexed citations
14.
Hodný, Zdeněk, Milan Reiniš, Soňa Hubáčková, Pavla Vašicová, & Jiří Bártek. (2015). Interferon gamma/NADPH oxidase defense system in immunity and cancer. OncoImmunology. 5(2). e1080416–e1080416. 17 indexed citations
15.
Sabová, L, et al.. (2014). TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence. Cellular Signalling. 26(12). 2903–2911. 41 indexed citations
16.
Hubáčková, Soňa, Kateřina Krejčíková, Robert Strauss, et al.. (2014). Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells. Cell Death and Differentiation. 22(6). 898–911. 59 indexed citations
17.
Hubáčková, Soňa, Kateřina Krejčíková, Jiří Bártek, & Zdeněk Hodný. (2012). Interleukin 6 Signaling Regulates Promyelocytic Leukemia Protein Gene Expression in Human Normal and Cancer Cells. Journal of Biological Chemistry. 287(32). 26702–26714. 31 indexed citations
19.
Hubáčková, Soňa, Zora Nováková, Kateřina Krejčíková, et al.. (2010). Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling. Cell Cycle. 9(15). 3157–3171. 44 indexed citations
20.
Nováková, Zora, Soňa Hubáčková, Lenka Rossmeislová, et al.. (2009). Cytokine expression and signaling in drug-induced cellular senescence. Oncogene. 29(2). 273–284. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026